A novel association between cytotoxin-associated gene A (CagA) positive strain of Helicobacter pylori and unexplained recurrent early pregnancy loss.

OBJECTIVE: To assess whether or not there is an association between the cytotoxin-associated gene A (CagA)-positive strain of Helicobacter (H.) pylori and unexplained recurrent early pregnancy loss (REPL). METHODS: A case control study was conducted in a tertiary care maternity centre during a one-year period. Ninety-six women with first trimester unexplained REPL admitted for surgical or medical termination of pregnancy were included in the study group (group 1), along with 96 women who suffered a first trimester missed abortion but had no history of REPL and who were included in the control group (group 2). Sera from all these women were collected for detection of the CagA line of IgG type of H. pylori using an immunoblotting assay. The main outcome measure was the association between the CagA-positive strain of H. pylori and unexplained REPL. RESULTS: A significantly greater proportion of women were seropositive for the CagA- H. pylori strain in group 1 than in group 2 (71 [74%] vs. 51 [53%], respectively; p = 0.003). CONCLUSION: The CagA-positive strain of H. pylori seems to be significantly more prevalent among women with unexplained REPL when compared to women with a single missed abortion.

Measurement of maternal serum amyloid A as a novel marker of preterm birth.

OBJECTIVE: To study the association between maternal serum amyloid A (mSAA) levels and preterm birth (PTB). METHODS: This prospective observational nested case control study was conducted at Ain Shams University Maternity Hospital, Cairo, Egypt, between May 2017 and December 2017. The study recruited pregnant women at 26-34 weeks presented with threatened preterm labor (PTL). Women with PTB were included in cases group while control group included women who continued pregnancy and delivered at term. Serum samples were collected to measure mSAA levels. The main outcome of the study was the association between mSAA levels and PTB. Secondary outcomes included neonatal intensive care unit admissions and neonatal mortality. RESULTS: Fifty-eight women were included in the final analysis (29 in each group). Women with PTB had a statistically significant higher mSAA levels [5.1 (4.5-7.7) vs. 1.2 (0.0-2.5) mg/l, for cases and controls respectively, p < .001]. Higher mSAA levels were also observed among women whose babies were admitted to NICU, but there was no significant relation between mSAA level and neonatal death. A statistically significant negative correlation was found between mSAA and gestational age at delivery and neonatal birth weight. mSAA had an excellent value to predict PTB (AUC = 0.972 [95% CI, 0.891-0.998], p < .0001), fair value to predict admission to NICU and a poor value to predict neonatal death. CONCLUSIONS: mSAA level was found to be elevated among women with threatened PTL who end with PTB; mSAA is a potentially useful predictive marker of PTB that warrant further study. CLINICALTRIALS.GOV: NCT01639027.